BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SOFIE - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SOFIE
X-ORIGINAL-URL:https://sofie.com
X-WR-CALDESC:Events for SOFIE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220526T153000
DTEND;TZID=America/New_York:20220526T163000
DTSTAMP:20260408T180846
CREATED:20220515T024729Z
LAST-MODIFIED:20220515T025109Z
UID:2285-1653579000-1653582600@sofie.com
SUMMARY:Seeing the Difference: Advances in the Imaging of Neuroendocrine Tumors
DESCRIPTION:Presenter: Jesse R. Johnson\, BS\, CNMT\nSenior Area Business Manager for Curium \nJess is currently a Senior Area Business Manager with Curium and support their traditional products line such as Mo-99 generators\, Thallium\, xenon etc.\, in addition to Cu-64 DOTOTATE\, Detectnet and most recently I-123 Ioflupane injection. He has had multiple responsibilities and sales positions with Curium over the past 15 years dating back to Tyco Healthcare Mallinckrodt. Prior to this he worked for Dupont/BMS Medical Imaging supporting Cardiolite from the Medical Affairs side of the business. Jesse has also worked 15 years clinically at the Marshfield Clinic in Marshfield\, WI. \nDate: May 26\, 2022\nTime: 3:30pm EDT \nRegister Now\nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Jesse will: \n\nReview the structure\, function\, and distribution of neuroendocrine tumors (NETs)\nDescribe the key attributes of NETs that are necessary to understand the advantages and disadvantages of current imaging techniques and technologies\nIdentify currently used imaging technologies for NETs and the benefits and limitations of each
URL:https://sofie.com/event/seeing-the-difference-advances-in-the-imaging-of-neuroendocrine-tumors/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220428T153000
DTEND;TZID=America/New_York:20220428T163000
DTSTAMP:20260408T180846
CREATED:20220416T231255Z
LAST-MODIFIED:20220515T025319Z
UID:2107-1651159800-1651163400@sofie.com
SUMMARY:Advantages of Cardiac PET MPI
DESCRIPTION:Presenter: April Mann\, MBA\, CNMT\, NCT\, RT(N)\nVP\, Clinical Development for IONETIX \nMs. Mann is the VP\, Clinical Development for Ionetix. Before entering the industry sector\, she was employed by the Hartford Healthcare System since 1992 and held various roles within the organization and Heart & Vascular Institute. She has been a nuclear medicine technologist since 1989 and has a BA in Healthcare Management and a Masters’\, Business Administration. Ms. Mann has been active within the nuclear medicine/nuclear cardiology community most notably serving as the President\, Society of Nuclear Medicine and Molecular Imaging-Technologist Section She has over 27 publications and has given over 200 presentations on various topics in nuclear medicine\, cardiology and quality and outcomes.  She is well respected in the Imaging community and has several years of leadership\, operations\, and business experience in healthcare. \nDate: April 28\, 2022\nTime: 3:30pm EDT \nRegister Now\nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers \nIn this webinar\, Ms. Mann will: \n\nDiscuss the clinical advantages of Cardiac PET MPI\nDiscuss the considerations for acquisition including protocol and radiopharmaceutical selections\nDiscuss advantages and considerations of performing myocardial blood flow\nDiscuss applications for infection and inflammation imaging
URL:https://sofie.com/event/advantages-of-cardiac-pet-mpi/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220331T153000
DTEND;TZID=America/New_York:20220331T163000
DTSTAMP:20260408T180846
CREATED:20220309T224509Z
LAST-MODIFIED:20220309T224834Z
UID:2100-1648740600-1648744200@sofie.com
SUMMARY:Neuroendocrine Tumor Imaging
DESCRIPTION:Presenter: Dr. Robert Bridwell\, MD\, MBA\nMedical Advisor at SOFIE \nDr. Robert Bridwell\, medical advisor to SOFIE\, and co-founder of PETLinQ\, is a board-certified physician in both Internal Medicine and Nuclear Medicine. He has extensive knowledge and experience in continuous quality improvement programs for PET and PET/CT imaging\, utilizing physician empowerment training\, protocol development assistance\, and quality assurance guidelines. In the last five years\, Dr. Bridwell has been invited to make numerous presentations\, which have included more than 1200 hours of CME credit delivered to more than 350 institutions\, 100 professional society meetings and more than 150 radiology groups throughout the United States\, Canada and Europe. \nDate: March 31\, 2022\nTime: 3:30pm EDT \nWho should attend? PET Interpreters\, Technologists\, Referring Physicians\, Marketers  \nIn this webinar\, Dr. Bridwell will: \n\nhelp you to understand the application of Dotatate imaging for the management of neuroendocrine tumors\nreview the NETPET scoring system and how it may be applied to therapy selection\nshow contrast in the use of Ga-68 labeled and Cu-64 labeled Dotatate imaging\n\nRegister Now
URL:https://sofie.com/event/neuroendocrine-tumor-imaging/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220126T153000
DTEND;TZID=America/New_York:20220126T163000
DTSTAMP:20260408T180846
CREATED:20220103T235930Z
LAST-MODIFIED:20220104T002005Z
UID:2063-1643211000-1643214600@sofie.com
SUMMARY:Recognizing Signs and Artifacts in Neuraceq® (F18 florbetaben) PET Scans…How the NM/PET Technologist Ensures Excellent Image Quality
DESCRIPTION:Presenter: Barbara J Grabher BS\, CNMT\, RT(N)\, NCT\, FSNMMI-TS\nClinical Applications Specialist for Life Molecular Imaging \nBarbara Grabher has been in the field of Nuclear Medicine for over 38 years\, she earned her Associates Degree in Nuclear Medicine from Delaware Technical and Community College in 1983 and earned her bachelor’s degree in Organizational Management from Wilmington University in 2018. She is board-certified by the American Registry of Radiologic Technologists and the Nuclear Medicine Technology Certification Board in both Nuclear Medicine and as a Nuclear Cardiology Technologist. Ms. Grabher received her Nuclear Medicine fellowship status by the SNMMI Technologist section in June 2021 being one of only 109 Nuclear Medicine technologist in the country to receive this recognition. She’s given presentations at the local level as well as nationally\, on topics related to both nuclear cardiology and neurology specializing in DaT imaging and movement disorders as well as amyloid imaging. She’s had 4 manuscripts published in the JNMT Technologist Journal on various topics. Ms. Grabher holds Six Sigma Greenbelt\, LEAN and Blackbelt Certificates specializing in Healthcare. She is a member of the Society of Nuclear Medicine Technologist Section and has affiliations that include the Society of Nuclear Medicine\, and the American Society of Radiologic Technologists. Ms. Grabher is currently a Clinical Applications Specialist for Life Molecular Imaging supporting the amyloid plaque imaging agent Neuraceq.\n  \nDate: January 26\, 2022\nTime: 3:30pm EST \nWho should attend?\nPET Interpreters\, Technologists\, Referring Physicians \nIn this webinar\, Ms. Grabher will help you to: \n\nunderstand the importance of β-amyloid imaging and how scan results can change patient management decisions\nrecognize and understand how different signs and artifacts can affect image quality and potential patient outcomes if images are not interpreted correctly\n\nevaluate and recognize Neuraceq® imaging pitfalls and artifacts as well as different distribution patters of Neuraceq®\n\nRegister Now
URL:https://sofie.com/event/recognizing-signs-and-artifacts-in-neuraceq-f18-florbetaben-pet-scanshow-the-nm-pet-technologist-ensures-excellent-image-quality/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/06/Doc2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211027T153000
DTEND;TZID=America/New_York:20211027T163000
DTSTAMP:20260408T180846
CREATED:20211019T215654Z
LAST-MODIFIED:20211019T220209Z
UID:2020-1635348600-1635352200@sofie.com
SUMMARY:Initiatives in Radiation Safety
DESCRIPTION:Presenter: James G. Fongheiser\, BS\,MS – Independent Consultant – Health Physics\, Radiation Protection and Licensing \nJames Fongheiser\, BS\, MS\, is an independent consultant in health physics\, providing assistance and services in radiation protection and licensing.  \nDate: October 27\, 2021\nTime: 3:30pm EDT \nWho should attend?\nPET Interpreters\, Technologists\, Referring Physicians \nUnderstand the relevant\, key aspects of occupational Exposure Reduction\, including: \n\nideal facilities and engineering controls\ncultural obstacles\npresent day status\n\nUnderstand the relevant\, key aspects of compliance issues and their relevance to US\, by reviewing: \n\nNRC Information Notices\, and \nState Inspection material\n\nUnderstand the relevant\, key aspects of DOT Compliance for Hospitals and outpatient facilities for: \n\nReceipt of radiopharmaceuticals\nReceipt of sealed sources\nReturn or disposal of radioactive material\n\nRegister Now
URL:https://sofie.com/event/initiatives-in-radiation-safety/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/10/RadiationSafety.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210930
DTEND;VALUE=DATE:20211001
DTSTAMP:20260408T180846
CREATED:20210916T220623Z
LAST-MODIFIED:20210916T223251Z
UID:1979-1632960000-1633046399@sofie.com
SUMMARY:Nuclear Medicine Accreditation
DESCRIPTION:Presenter: Carl Grieco\, CNMT\, BS\, Nuclear Medicine/PET Accreditation Consultant \nCarl is a certified nuclear medicine technologist and a qualified radiation safety officer with extensive experience in nuclear medicine accreditation. Carl understands the time demands on the nuclear medicine staff and the effort it takes to obtain and maintain accreditation. Carl actually worked as a site visitor for IAC-Nuclear (ICANL) and the American College of Radiology (ACR) for many years before he began providing accreditation services as a consultant. \nObjectives: \n\nLearn about the different commissions that are approved by CMS.\nDecide which is the best commission for your facility.\nHow accreditation can be used in MIPS\n\nDate: September 30\, 2021 \nTime: 3:30 pm EDT \n***(Approved for 1.0 CE credit from SNMMI CEC10384) \nRegister Now
URL:https://sofie.com/event/nuclear-medicine-accreditation/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/09/webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210715
DTEND;VALUE=DATE:20210721
DTSTAMP:20260408T180846
CREATED:20210626T185833Z
LAST-MODIFIED:20210626T190453Z
UID:1935-1626307200-1626825599@sofie.com
SUMMARY:How to Technically Maximize the Quality of the Information From the Study (CEC10184)
DESCRIPTION:How to Technically Maximize the Quality of the Information From the Study (CEC10184)\nPresenter: Dr. Robert Bridwell\, Board Certified in Nuclear Medicine and Internal Medicine and is currently Medical Advisor for SOFIE and Phyllis Hoelsworth\, Director of Product Launch for SOFIE \nIn this session\, Dr. Bridwell will describe the biodistribution of DCFPyl imaging (F-18 PSMA) to help you to understand the technical maneuvers that can be done to improve the sensitivity to detect pelvic disease and distant metastatic disease. He will also describe the most important clinical characteristics that may impact the sensitivity of the study to include medications\, uptake time and type of patient being imaged. Finally\, he will outline the important questions to ask the patient prior to the scanning process. \nJuly 15\n3:30pm EDT / 12:30pm PDT \nJuly 20\n7:00pm EDT / 4:00 pm PDT \nREGISTER NOW
URL:https://sofie.com/event/how-to-technically-maximize-the-quality-of-the-information-from-the-study-cec10184/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/06/Doc2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210611
DTEND;VALUE=DATE:20210616
DTSTAMP:20260408T180846
CREATED:20210512T041705Z
LAST-MODIFIED:20210517T194637Z
UID:1696-1623369600-1623801599@sofie.com
SUMMARY:SNMMI 2021 Virtual Annual Meeting
DESCRIPTION:The SNMMI 2021 Annual Meeting is recognized as the premier educational\, scientific\, research\, and networking event in nuclear medicine and molecular imaging. The four day event\, taking place each June\, provides physicians\, technologists\, pharmacists\, laboratory professionals\, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic.
URL:https://sofie.com/event/snmmi-2021-virtual-annual-meeting/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/05/AM2021_We_are_Exhibiting.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210604T153000
DTEND;TZID=America/New_York:20210604T163000
DTSTAMP:20260408T180846
CREATED:20210512T041053Z
LAST-MODIFIED:20210519T001032Z
UID:1694-1622820600-1622824200@sofie.com
SUMMARY:Bringing PSMA PET/CT Imaging to Your Patients
DESCRIPTION:Presenter: Dr. Robert Bridwell\, Board Certified in Nuclear Medicine and Internal Medicine and is currently Medical Advisor for SOFIE and Phyllis Hoelsworth\, Director of Product Launch for SOFIE \nDr. Bridwell will review the patient profile selection for PSMA imaging and how PSMA imaging will benefit patients as well as where theranostics fits in the prostate cancer space. Phyllis Hoelsworth will then review marketing strategies and best practices for building a successful PSMA program. \nJune 4\n7:00pm EDT / 4:00 pm PDT \nREGISTER NOW
URL:https://sofie.com/event/bringing-psma-pet-ct-imaging-to-your-patients/
ATTACH;FMTTYPE=image/jpeg:https://sofie.com/wp-content/uploads/2021/05/Man3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210602T153000
DTEND;TZID=America/New_York:20210602T163000
DTSTAMP:20260408T180846
CREATED:20210425T181707Z
LAST-MODIFIED:20210512T040842Z
UID:1148-1622647800-1622651400@sofie.com
SUMMARY:Bringing PSMA PET/CT Imaging to Your Patients
DESCRIPTION:Bringing PSMA PET/CT Imaging to Your Patients\nPresenter: Dr. Robert Bridwell\, Board Certified in Nuclear Medicine and Internal Medicine and is currently Medical Advisor for SOFIE and Phyllis Hoelsworth\, Director of Product Launch for SOFIE \nDr. Bridwell will review the patient profile selection for PSMA imaging and how PSMA imaging will benefit patients as well as where theranostics fits in the prostate cancer space. Phyllis Hoelsworth will then review marketing strategies and best practices for building a successful PSMA program. \nJune 2\n3:30pm EDT / 12:30pm PDT \nJune 4\n7:00pm EDT / 4:00 pm PDT \nREGISTER NOW
URL:https://sofie.com/event/prostate-cancer-webinar-series/
ATTACH;FMTTYPE=image/png:https://sofie.com/wp-content/uploads/2021/04/Man2.png
END:VEVENT
END:VCALENDAR